Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Generic compound preparation BNF 0101021
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Bismuth subsalicylate 262.5mg chewable tablets sugar free
010102100AAAIAI
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 223 |
|
Bismuth subsalicylate 17.5mg/1ml oral suspension sugar free
010102100AAAGAG
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 122 |
|
Calcium carb 680mg/Magnesium carb heavy 80mg chew tab
010102100AAAFAF
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 9 |
|
Generic Rennie Deflatine chewable tablets sugar free
010102100AAABAB
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | 3 |
|
Calcium carb 680mg/Magnesium carb heavy 80mg chew tab SF
010102100AAAHAH
|
Generic compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.